Skip to main content

Table 3 HIV risks among transgender women who reported always and not always using condoms with male non-commercial partners (n = 1202)

From: Factors associated with condom use with non-commercial partners among sexually-active transgender women in Cambodia: findings from a national survey using respondent-driven sampling

HIV risks    Condom use with male non-commercial partner in the past three months
Crude n (%) RDS-adjusted % (95% CI) RDS-adjusted % (always) RDS-adjusted % (not always) P-value*
Main role in anal sex with men in the past 12 months
Insertive 26 (2.2) 2.0 (1.0, 2.9) 2.9 1.3 0.32
Receptive 1043 (86.8) 85.7 (82.8, 88.6) 84.9 85.9  
Both 133 (11.1) 12.3 (9.5, 15.1) 12.3 12.7  
Had sex with male commercial partners in the past 3 months 444 (36.9) 34.0 (29.6, 38.3) 33.3 36.3 0.43
Had ≥2 male commercial partners in the past 3 months 310 (25.8) 22.5 (19.1, 25.9) 21.5 24.3 0.42
Always used condoms with male commercial partners 243 (20.2) 17.6 (14.1, 21.0) 14.1 24.9 < 0.001
Had an STI symptom in the past 12 months 175 (14.6) 14.7 (11.5, 17.8) 11.3 17.6 0.005
Tested for HIV in the past 6 months 617 (51.3) 42.9 (37.9, 47.8) 51.6 43.8 0.04
Perceived likelihood of HIV infection
Very Likely 128 (10.7) 7.0 (5.4, 8.6) 6.2 9.8 < 0.001
Likely 693 (57.7) 58.0 (54.0, 62.0) 48.5 63.3  
Unlikely 293 (24.4) 27.1 (23.4, 30.8) 33.8 19.8  
Very Unlikely 88 (7.3) 7.9 (5.9, 10.0) 9.9 5.3  
  1. Abbreviations: CI confidence interval, HIV human immunodeficiency virus, RDS respondent driven sampling, STI sexually transmitted infections
  2. * Chi-square test (or Fisher’s exact test when a cell count was smaller than 5) was used